| Analysis | Metabolite Name | Measured Value | Units | Cell type | Material | Treatment |
|---|---|---|---|---|---|---|
| LC/MS positive ion mode | PYRIDOXAMINE | 17433 | Peak area | 293T | Media | No transfection |
| LC/MS positive ion mode | PYRIDOXAMINE | 76384 | Peak area | 293T | Media | WT NPM-ALK tf |
| LC/MS positive ion mode | PYRIDOXAMINE | 84342 | Peak area | 293T | Media | No transfection |
| LC/MS positive ion mode | PYRIDOXAMINE | 88769 | Peak area | 293T | Media | WT NPM-ALK tf |
| LC/MS positive ion mode | PYRIDOXAMINE | 94830 | Peak area | SUPM2 | Cells | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 94872 | Peak area | SUPM2 | Cells | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 95261 | Peak area | SUPM2 | Cells | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 110799 | Peak area | SUPM2 | Cells | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 111522 | Peak area | SUPM2 | Cells | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 114134 | Peak area | 293T | Media | K210R NPM-ALK tf |
| LC/MS positive ion mode | PYRIDOXAMINE | 115224 | Peak area | DEL | Cells | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 115293 | Peak area | SUPM2 | Cells | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 115368 | Peak area | SUPM2 | Cells | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 117601 | Peak area | 293T | Cells | WT NPM-ALK tf |
| LC/MS positive ion mode | PYRIDOXAMINE | 119176 | Peak area | 293T | Media | WT NPM-ALK tf |
| LC/MS positive ion mode | PYRIDOXAMINE | 119582 | Peak area | 293T | Cells | K210R NPM-ALK tf |
| LC/MS positive ion mode | PYRIDOXAMINE | 121932 | Peak area | SUPM2 | Cells | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 124389 | Peak area | 293T | Cells | WT NPM-ALK tf |
| LC/MS positive ion mode | PYRIDOXAMINE | 125868 | Peak area | 293T | Cells | K210R NPM-ALK tf |
| LC/MS positive ion mode | PYRIDOXAMINE | 126865 | Peak area | SUPM2 | Cells | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 127028 | Peak area | 293T | Cells | K210R NPM-ALK tf |
| LC/MS positive ion mode | PYRIDOXAMINE | 128928 | Peak area | DEL | Cells | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 129362 | Peak area | DEL | Cells | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 131244 | Peak area | SUPM2 | Cells | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 133387 | Peak area | 293T | Cells | No transfection |
| LC/MS positive ion mode | PYRIDOXAMINE | 138628 | Peak area | 293T | Cells | No transfection |
| LC/MS positive ion mode | PYRIDOXAMINE | 140247 | Peak area | SUDHL-1 | Cells | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 140934 | Peak area | DEL | Cells | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 142364 | Peak area | 293T | Cells | WT NPM-ALK tf |
| LC/MS positive ion mode | PYRIDOXAMINE | 142496 | Peak area | SUDHL-1 | Cells | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 143431 | Peak area | 293T | Cells | WT NPM-ALK tf |
| LC/MS positive ion mode | PYRIDOXAMINE | 143497 | Peak area | 293T | Cells | K210R NPM-ALK tf |
| LC/MS positive ion mode | PYRIDOXAMINE | 143612 | Peak area | 293T | Cells | WT NPM-ALK tf |
| LC/MS positive ion mode | PYRIDOXAMINE | 143883 | Peak area | DEL | Cells | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 145395 | Peak area | 293T | Media | No transfection |
| LC/MS positive ion mode | PYRIDOXAMINE | 145482 | Peak area | 293T | Media | No transfection |
| LC/MS positive ion mode | PYRIDOXAMINE | 146047 | Peak area | DEL | Cells | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 152357 | Peak area | 293T | Cells | No transfection |
| LC/MS positive ion mode | PYRIDOXAMINE | 154730 | Peak area | DEL | Cells | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 156349 | Peak area | DEL | Cells | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 158517 | Peak area | SUDHL-1 | Cells | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 162188 | Peak area | DEL | Cells | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 162723 | Peak area | DEL | Cells | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 167442 | Peak area | 293T | Media | No transfection |
| LC/MS positive ion mode | PYRIDOXAMINE | 169757 | Peak area | 293T | Media | K210R NPM-ALK tf |
| LC/MS positive ion mode | PYRIDOXAMINE | 170462 | Peak area | 293T | Cells | K210R NPM-ALK tf |
| LC/MS positive ion mode | PYRIDOXAMINE | 177168 | Peak area | 293T | Cells | No transfection |
| LC/MS positive ion mode | PYRIDOXAMINE | 179542 | Peak area | 293T | Cells | No transfection |
| LC/MS positive ion mode | PYRIDOXAMINE | 185716 | Peak area | SUDHL-1 | Cells | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 190390 | Peak area | 293T | Media | K210R NPM-ALK tf |
| LC/MS positive ion mode | PYRIDOXAMINE | 202846 | Peak area | 293T | Media | WT NPM-ALK tf |
| LC/MS positive ion mode | PYRIDOXAMINE | 218283 | Peak area | SUDHL-1 | Cells | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 219168 | Peak area | SUDHL-1 | Cells | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 227971 | Peak area | SUDHL-1 | Cells | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 228188 | Peak area | DEL | Media | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 231880 | Peak area | SUDHL-1 | Cells | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 248570 | Peak area | DEL | Media | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 252433 | Peak area | SUDHL-1 | Cells | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 253579 | Peak area | DEL | Media | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 267709 | Peak area | 293T | Media | WT NPM-ALK tf |
| LC/MS positive ion mode | PYRIDOXAMINE | 276858 | Peak area | SR786 | Media | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 279891 | Peak area | 293T | Media | K210R NPM-ALK tf |
| LC/MS positive ion mode | PYRIDOXAMINE | 280702 | Peak area | DEL | Media | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 285300 | Peak area | SR786 | Media | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 286299 | Peak area | 293T | Media | K210R NPM-ALK tf |
| LC/MS positive ion mode | PYRIDOXAMINE | 286973 | Peak area | SR786 | Media | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 289365 | Peak area | SR786 | Media | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 292618 | Peak area | DEL | Media | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 294435 | Peak area | SUDHL-1 | Media | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 296137 | Peak area | SUDHL-1 | Media | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 296924 | Peak area | DEL | Media | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 300890 | Peak area | SUPM2 | Media | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 306900 | Peak area | SUDHL-1 | Media | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 307138 | Peak area | SR786 | Media | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 307809 | Peak area | SUPM2 | Media | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 308688 | Peak area | DEL | Media | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 309673 | Peak area | SUDHL-1 | Media | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 311014 | Peak area | SUDHL-1 | Media | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 316679 | Peak area | SUPM2 | Media | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 317547 | Peak area | SR786 | Cells | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 323518 | Peak area | SUPM2 | Media | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 324534 | Peak area | SR786 | Cells | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 325431 | Peak area | SUPM2 | Media | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 327156 | Peak area | SR786 | Media | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 327681 | Peak area | SUDHL-1 | Media | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 328475 | Peak area | DEL | Media | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 333822 | Peak area | SUDHL-1 | Media | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 334629 | Peak area | SUPM2 | Media | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 338649 | Peak area | SUDHL-1 | Media | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 348863 | Peak area | SUDHL-1 | Media | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 350414 | Peak area | SR786 | Cells | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 350792 | Peak area | DEL | Media | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 352735 | Peak area | SUPM2 | Media | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 354543 | Peak area | SUPM2 | Media | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 357834 | Peak area | SR786 | Cells | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 360094 | Peak area | SR786 | Media | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 367985 | Peak area | SUPM2 | Media | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 381258 | Peak area | SR786 | Cells | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 392626 | Peak area | SR786 | Cells | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 394851 | Peak area | SUDHL-1 | Media | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 402503 | Peak area | SR786 | Media | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 420119 | Peak area | SR786 | Media | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 440652 | Peak area | SR786 | Media | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 460233 | Peak area | SR786 | Cells | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 465374 | Peak area | DEL | Media | DMSO |
| LC/MS positive ion mode | PYRIDOXAMINE | 502689 | Peak area | SR786 | Cells | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 506360 | Peak area | SR786 | Cells | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 527431 | Peak area | SUDHL-1 | Cells | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | 567182 | Peak area | SR786 | Cells | CEP-26939 |
| LC/MS positive ion mode | PYRIDOXAMINE | Peak area | SUPM2 | Media | CEP-26939 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|